TY - JOUR
T1 - A constraint programming model for makespan minimisation in batch manufacturing pharmaceutical facilities
AU - Awad, Mohamed
AU - Mulrennan, Konrad
AU - Donovan, John
AU - Macpherson, Russell
AU - Tormey, David
N1 - Publisher Copyright:
© 2021
PY - 2022/1
Y1 - 2022/1
N2 - This work introduces a constraint programming (CP) model to minimise the makespan of a large scheduling problem in batch pharmaceutical manufacturing facilities. The model included campaign-manufacturing, sequence-dependent changeover, forbidden product-equipment assignment, non-working periods, limited renewable resources, finite intermediate/non-intermediate storage policies and preemptive and non-preemptive operations. The model was tested by scheduling two real examples. Each example consisted of two cases. Case A used the actual number of workers per shift. Case B involved reorganising the shift pattern of the workers. The results from the model were qualitatively validated and compared with the baseline schedules. The makespan of the first example decreased by 24.35% for case 1.A and 38.63% for case 1.B. The second example reported a 2.17% decrease in makespan for case 2.A and 16.67% decrease for case 2.B. This demonstrates the success of the proposed model as a simulation tool to identify the manufacturing bottlenecks by running what-if scenarios.
AB - This work introduces a constraint programming (CP) model to minimise the makespan of a large scheduling problem in batch pharmaceutical manufacturing facilities. The model included campaign-manufacturing, sequence-dependent changeover, forbidden product-equipment assignment, non-working periods, limited renewable resources, finite intermediate/non-intermediate storage policies and preemptive and non-preemptive operations. The model was tested by scheduling two real examples. Each example consisted of two cases. Case A used the actual number of workers per shift. Case B involved reorganising the shift pattern of the workers. The results from the model were qualitatively validated and compared with the baseline schedules. The makespan of the first example decreased by 24.35% for case 1.A and 38.63% for case 1.B. The second example reported a 2.17% decrease in makespan for case 2.A and 16.67% decrease for case 2.B. This demonstrates the success of the proposed model as a simulation tool to identify the manufacturing bottlenecks by running what-if scenarios.
KW - Batch production scheduling
KW - Constraint programming
KW - Flow-shop environment
KW - Makespan minimisation
KW - Multi-product
KW - Pharmaceuticals
UR - http://www.scopus.com/inward/record.url?scp=85117611890&partnerID=8YFLogxK
U2 - 10.1016/j.compchemeng.2021.107565
DO - 10.1016/j.compchemeng.2021.107565
M3 - Article
AN - SCOPUS:85117611890
SN - 0098-1354
VL - 156
JO - Computers and Chemical Engineering
JF - Computers and Chemical Engineering
M1 - 107565
ER -